baber/WOPTO huggingface dataset:
Patent EP-1204325-B1 (EP)
Inventor: LAYZELL DAVID B
IPC: C05D9/00
Filed: 2000-07-24
Granted: 2004-10-27
Abstract: This invention provides methods of enhancing plant growth or yield, comprising exposing soil to hydrogen gas (H<SUB>2</SUB>), and growing plants in the soil. The H<SUB>2 </SUB>gas employed can be generated by electrolysis of water, produced by H<SUB>2 </SUB>evolving microorganisms, and/or produced by legumes. In accordance with the invention, soil can be exposed to H<SUB>2 </SUB>and plants then grown in it, or H<SUB>2 </SUB>can be applied directly to soil in which plants are already growing. In one embodiment, the invention comprises obtaining an aqueous extract from H<SUB>2</SUB>-treated soil, and applying the extract to soil, seeds, and or plant roots.
Patent EP-1204318-B1 (EP)
Inventor: LEWIS DAVID CHARLES
IPC: A01N57/20
Filed: 2000-08-17
Granted: 2004-10-13
Abstract: L'invention porte sur des tensioactifs qui améliorent également la bioefficacité des herbicides. Ces tensioactifs comprennent: (i) des monoesters de phosphate d'amine éthoxylates de suif, seuls ou en combinaison avec des diesters de phosphate d'amine éthoxylates de suif; ou (ii) des monoesters de phosphate alcoxylés d'amine éthoxylates de suif, seuls ou en combinaison avec des diesters de phosphate alcoxylés d'amine éthoxylates de suif. La présente invention porte également sur des compositions herbicides qui contiennent ces tensioactifs. Ces compositions herbicides comprennent un ingrédient actif herbicide, un tensioactif de l'invention et éventuellement un ou plusieurs supports de formulation. Les compositions herbicides s'avèrent n'avoir qu'une légère tendance à irriter les yeux et la peau. Cette invention porte également sur un procédé visant à éliminer les mauvaises herbes ou végétation non désirée à l'aide de ces compositions herbicides.
Patent EP-1237425-B1 (EP)
Inventor: KAMM VOLKER
IPC: A23L3/375
Filed: 2000-09-29
Granted: 2004-02-25
Abstract: A device and a method for cooling material exposes a material to a certain supply of cryogenic coolant using a conveying device. The configuration of the conveying device permits airtight packaging of the material and is designed according to a principle that is very similar to the paternoster conveying principle. The temperature in the device for cooling material can be set by metering devices for the cryogenic coolant. The airtight packaging of the material and the adjustable temperature setting provide an energy-efficient freezing unit with a small floor space requirement.
Patent EP-1224081-B1 (EP)
Inventor: OLSEN DAVID
IPC: B41J2/175
Filed: 2000-10-27
Granted: 2006-12-20
Abstract: The present disclosure relates to an ink container for providing ink to an inkjet printhead. The ink container includes a reservoir for containing ink. Also included in the ink container is at least one continuous fiber defining a three dimensional porous member. The at least one continuous fiber is bonded to itself at points of contact to form a self-sustaining structure that is disposed within the reservoir for retaining ink. Ink is drawn from the self-sustaining structure and provided to the inkjet printhead.
Patent EP-1242586-B1 (EP)
Inventor: MAKEYEV EUGENY
IPC: C12N9/10
Filed: 2000-12-21
Granted: 2010-10-13
Abstract: A polymerase protein originating from a dsRNA virus catalyzes RNA synthesis using ssRNA, dsRNA, ssDNA, or dsDNA templates. Such a polymerase can be purified from a dsRNA virus, and a protein having the amino acid sequence of such a polymerase is useful in methods and kits for in vitro RNA synthesis. A polymerase of the invention is processive, has very high RNA-polymerization rate and does not require primer for the initiation of RNA synthesis, although it is also able to initiate RNA synthesis in the presence of a primer. Primer-independent synthesis is especially useful in amplifying RNA for quantitation of RNA species in the sample and their identification by direct sequencing. This methodology is especially useful in detecting pathogenic parasites and differences in gene expression levels associated with diseases.
Patent EP-1176640-B1 (EP)
Inventor: EFLAND TAYLOR R
IPC: H01L27/088
Filed: 2001-07-27
Granted: 2008-02-20
Abstract: A semiconductor integrated circuit comprises contact pads located over active components, which are positioned to minimize the distance for power delivery between a selected pad and one or more corresponding active components, to which the power is to be delivered. This minimum distance further enhances dissipation of thermal energy released by the active components. More specifically, a semiconductor integrated circuit comprises a laterally organized power transistor, an array of power supply contact pads distributed over the transistor, means for providing a distributed, predominantly vertical current flow from the contact pads to the transistor, and means for connecting a power source to each of the contact pads. Positioning the power supply contact pads directly over the active power transistor further saves precious silicon real estate area. The means for vertical current flow include contact pads made of a stack of metal layers comprising refractory metals for adhesion, copper and nickel as stress-absorbing metals, and gold or palladium as bondable and solderable outermost metals. The means for connecting a power source include wire bonding and solder ball interconnection. <IMAGE>   <IMAGE>
Patent EP-1132683-B1 (EP)
Inventor: FEYE-HOHMANN JUERGEN
IPC: H05B41/02
Filed: 2001-02-26
Granted: 2006-10-25
Abstract: An electrical device such as a ballast for fluorescent lamps and including a housing, a terminal, and a catch element for connecting the terminal to the housing, the catch element including a catch leg for connecting the terminal to the catch element and for connecting the catch element to the housing. Accordingly, the electrical device is designed such that the individual terminal sites of the terminal have minimal positional tolerance so that the terminal can be wired with an automatic installation machine without the danger of misinsertions.
Patent EP-1213461-B1 (EP)
Inventor: RINGLER JUERGEN
IPC: F02D19/02
Filed: 2001-10-09
Granted: 2005-08-03
Abstract: Cryo-fuel (e.g. hydrogen) drawn from a heat-insulated tank (1) is fed to an i.c. combustion chamber (8) separately from the oxydant-containing gas fraction at minimum chamber compression, the cryo-fuel having prepared at feed pressure, i.e. by heating the fuel to b.p. The fuel tank is designed as a pressure vessel rated for an internal pressure equal to the pressure at which fuel is fed into the compressed intake air. The tank has its own heater (6) equipped with a heat exchanger using air intake to heat the fuel. A metering device (12) meters the intake air fed to the heat exchanger.
Patent EP-1324117-B1 (EP)
Inventor: STAHL WERNER
IPC: G03B42/04
Filed: 2001-12-20
Granted: 2006-12-20
Abstract: X-ray cassette (1) for a storage fluorescent screen (10) that is used for storing latent image information. The cassette has a seal (3) for opening and closing of the cassette and control means (20) for operation of the seal. The cassette has mounting elements (21, 22) for fixing the screen in position. The control means can be used to set three control steps corresponding to closed cassette, open cassette with the screen fixed and open cassette with screen released. <??>The invention also relates to a corresponding method for opening and closing the cassette.
Patent EP-1116984-B1 (EP)
Inventor: FRIEDMAN DEAN M
IPC: G02C9/00
Filed: 2001-01-02
Granted: 2003-03-26
Abstract: The clip-on sunglass assembly mounts on eyeglasses and has mirror image frame parts (10, 12). Each includes a lens retaining frame portion (14, 16) with a set of protruding "L" shaped eyeglass engaging prongs (26-32) and a bridge element (34, 36). A mechanism (38) is provided for connecting the bridge elements (34, 36) for movement between a proximate position, where the frame parts are relatively close to each other, and a remote position, where the frame parts are relatively far from each other. The connecting mechanism (38) includes at least one coil spring (50) situated within a cylindrical enclosure (40). The frame parts (10, 12) are normally biased toward each other by the spring (50) such that the prongs (26-32) securely engage the eyeglass frame. In one preferred embodiment, the enclosure (40) has an open end (42) which receives the bridge element (34) of one frame part (10). The spring (50) is operably situated between the enlarged end (46) of the bridge element and the interior wall (41) of the enclosure (40), adjacent the open end (42). In another preferred embodiment, separate springs and enclosures are provided for each bridge element. Each bridge element is fixed to the wall of the adjacent enclosure. A connecting bridge element extends between the enclosures. Within each enclosure, a spring is situated between the enlarged end of the connecting element and the enclosure wall. <IMAGE>   <IMAGE>
Patent EP-1245140-B1 (EP)
Inventor: HSIEH SHIH-PAN-YU
IPC: A01C1/04
Filed: 2001-03-27
Granted: 2005-07-06
Abstract: A sowing method of the plant seeds and the sowing materials used thereof is disclosed. The sowing method comprises the steps of a) providing a base with water-absorbing ability and humidity-maintaining ability, wherein the base includes a plurality of concavities, b) inlaying the plant seeds in the plural concavities of the base, and c) covering a cultivating material with the base, wherein each concavity has a void thereon for allowing a radicle of a corresponding plant seed to pierce therethrough and be rooted in the cultivating material while the corresponding plant seed is germinating. The base comprises light-blocking material for preventing the weeds from growing and is selected from a group consisting of a mulching paper, a fabric, a fiber and a polymer with natural decomposing ability. Therefore, the steps of sowing, soil-covering and weed-removal for agricultural production can be proceeded simultaneously and thus the cost is lowered.
Patent EP-1233648-B1 (EP)
Inventor: PAVLOVIC GINO DIPL-ING
IPC: H04R19/04
Filed: 2001-12-12
Granted: 2008-11-05
Abstract: An electrostatically operating electroacoustic transducer, operating as a sound receiver and configured to be mounted in a microphone capsule, has an electrode and a diaphragm connected to one another at a spacing from one another by a spacer ring, wherein on the electrode at least one first electric resistor is arranged which is connected to a power supply during operation of the microphone. The resistor is heated to prevent condensation of water vapor, and this improves the resistance of the microphone against ambient humidity.
Patent EP-1257212-B1 (EP)
Inventor: CRAGG ANDREW H
IPC: A61B17/16
Filed: 2001-02-14
Granted: 2009-09-02
Abstract: Apparatus for providing percutaneous access to the human sacral and lumbar vertebrae in alignment with a visualized, trans-sacral axial instrumentation/fusion (TASIF) line in a minimally invasive, low trauma, manner. A number of related TASIF surgical tool sets are provided by the present invention that are employed to form a percutaneous pathway from an anterior or posterior skin incision to a respective anterior or posterior target point of a sacral surface. The percutaneous pathway is generally axially aligned with an anterior axial instrumentation fusion line (AAIFL) or a posterior axial instrumentation/fusion line (PAIFL) extending from the respective anterior or posterior target point through at least one sacral vertebral body and one or more lumbar vertebral body in the cephalad direction and visualized by radiographic or fluoroscopic equipment. The anterior or posterior percutaneous pathway so formed enables introduction of further tools and instruments for boring one or more respective anterior or posterior TASIF bores in the cephalad direction through the one or more vertebral bodies and intervertebral spinal discs, if present. A single anterior or posterior TASIF bores is preferably aligned axially with the respective visualized AAIFL or PAIFL, and plural anterior or posterior TASIF bore are preferably aligned in parallel with the respective visualized AAIFL or PAIFL. Introduction of spinal implants and instruments is enabled by the provision of the percutaneous pathway in accordance with the present invention and formation of the anterior or posterior TASIF bore(s).
Patent EP-1322956-B1 (EP)
Inventor: FINE KENNETH D
IPC: G01N33/543
Filed: 2001-03-13
Granted: 2007-05-02
Abstract: A method for food sensitivity panel testing (for sensitivities other than gluten sensitivity) by detecting IgA antibodies in serum is disclosed. A method for testing stool samples for the presence of particular antibodies, which is more sensitive and less invasive than prior art testing methods, is also disclosed for diagnosing immunologic food sensitivities. These methods of diagnosis may be used alone or in combination to further enhance the accuracy of diagnosis.
Patent EP-1287247-B1 (EP)
Inventor: MITTRICKER FRANK F
IPC: F01K23/10
Filed: 2001-03-19
Granted: 2011-06-29
Abstract: A method and system for generating power include using a cogeneration power system having a gas turbine. The gas turbine has a compressor section for receiving air to be compressed. The compressed air is fed to a combustor section where it is mixed with fuel and the fuel is burned to produce heated combustion gas. The heated combustion gas is expanded in an expander section to generate shaft work which is used to drive a generator or alternator for producing electric power. The heated combustion gas leaves the expander as turbine exhaust which is cooled by transferring at least part of its heat to the air ahead of the combustor.
Patent EP-1296616-B1 (EP)
Inventor: WERBLIN THEODORE P
IPC: A61F2/16
Filed: 2001-04-18
Granted: 2012-05-02
Abstract: A method of correcting optical aberrations and abnormalities within the optical system of an eye having an intraocular lens implanted therein. The method includes the step of measuring and determining the extent of the aberrations and abnormalities. Removing at least one removable component of the intraocular lens. Modifying at least one surface of the removable component to eliminate or correct the aberrations and abnormalities. Reinserting the modified removable component within the intraocular lens in the optical system through a same wound formed to originally implant the intraocular lens.
Patent EP-1275049-B1 (EP)
Inventor: AHERN FRANK W
IPC: G06F13/40
Filed: 2001-04-19
Granted: 2016-02-17
Abstract: An interface (20) comprises first electronics (26) adapted to interface parallel data from a parallel data bus (32) to a first bus, the first electronics (26) being adapted to connect to at least one PC card. The interface further comprises second electronics (30) adapted to interface parallel data from said parallel data bus (32) into serial data adapted to interface with a second remote bus, said second electronics (30), in the absence of a threshold detect signal from the second remote bus, converting said parallel data to said serial data without requiring any signal from said second remote bus. The interface (20) comprises electronics shared by the first electronics (26) and the second electronics (30) to interface to the parallel data bus (32).
Patent EP-1292591-B1 (EP)
Inventor: KATH JOHN CHARLES
IPC: A61K31/5377
Filed: 2001-06-14
Granted: 2005-02-02
Abstract: La présente invention concerne des composés représentés par la formule (1) ainsi que leurs sels acceptables sur le plan pharmaceutique, leurs promédicaments et leurs solvates. Dans cette formule, R?1, R3, R4, R5, R11¿, m et p sont tels que définis dans le descriptif de l'invention. Par ailleurs, cette invention concerne des méthodes de traitement de la croissance cellulaire anomale chez les mammifères consistant à leur administrer les composés de la formule (1), ainsi que des compositions pharmaceutiques renfermant les composés de la formule (1), destinées à traiter de tels troubles. De plus, cette invention concerne des méthodes de préparation des composés de la formule (1).
Patent EP-1292587-B1 (EP)
Inventor: EVANS WAYNE ERROL
IPC: B01J23/68
Filed: 2001-06-05
Granted: 2006-10-11
Abstract: There is provided a process for the vapor phase oxidation of ethylene to ethylene oxide in the presence of a supported highly selective silver-based catalyst, the process comprising operating fresh catalyst for an initial operation phase, then operating at a further operation phase when the catalyst has reached an advanced aged defined by a cumulative ethylene oxide production exceeding 1.5 kT EO per m3 of catalyst. In the further operation phase the composition of the reaction mixture is changed to contain from 1.1 to 4 times the concentration of ethylene used in the initial operation phase and the corresponding optimised and safe concentration of oxygen.
Patent EP-1313404-B1 (EP)
Inventor: SWANSON DAVID K
IPC: A61B18/14
Filed: 2001-08-08
Granted: 2004-01-02
Abstract: Surgical methods and apparatus for positioning diagnostic an therapeutic elements on the epicardium or other organ surface. The apparatus includes a tissue cooling apparatus.
Patent EP-1326923-B1 (EP)
Title: Dispersion d'un polymere preforme dans un polyol
Inventor: LUNDGARD RICHARD A
IPC: C08J3/09
Filed: 2001-09-10
Granted: 2008-09-03
Abstract: La présente invention concerne un processus de préparation d'une dispersion stable d'un polymère préformé dans un polyol au moyen d'un seul mélangeur. On mélange un polymère préformé dans des conditions thermiques et de cisaillement suffisantes, de manière à réduire ses particules à une taille souhaitée en présence d'un polyol. Cette invention a également trait à des dispersions stables de polymères dans des polyols et à des préparations de polyuréthanne renfermant des dispersions stables élaborées par le processus de cette invention.
Patent EP-1313537-B1 (EP)
Inventor: BLAZE MARTIN
IPC: B01D29/96
Filed: 2001-08-28
Granted: 2006-11-29
Abstract: L'invention utilise un système unique permettant initialement d'installer, d'enlever et de transporter des empilements de disques à cartouches. Cet appareil comprend un montant central et un élément de connexion placé de manière coopérative par rapport au montant auquel il est relié de façon fonctionnelle; et un adaptateur relié de manière fonctionnelle au montant, pour porter au moins un disque lorsque le montant est relié de manière fonctionnelle à une plaque d'appui, et pour porter au moins un disque pendant l'installation/déplacement d'au moins un disque de la plaque d'appui. Par ailleurs, l'invention concerne des systèmes et des procédés d'utilisation de cet appareil.
Patent EP-1329019-B1 (EP)
Inventor: HARDIN KEITH BRYAN
IPC: H03D3/24
Filed: 2001-09-20
Granted: 2010-11-10
Abstract: L'invention concerne un générateur d'horloge à spectre étalé (100) qui fournit un signal (300) avec une réponse en fréquence comportant plusieurs segments qui présentent tous un affaiblissement important d'au moins 10 dB des deux côtés de l'amplitude de crête de chaque segment sur la totalité du spectre de fréquence. Un synthétiseur de fréquence (de préférence une boucle à phase asservie) génère un signal de sortie (154) par la modulation de la fréquence de sortie à une vitesse prédéterminée entre une « borne inférieure » et une « borne supérieure » de fréquences de modulation. Afin de créer et de commander un profil à spectre segmenté, une valeur différente est introduite au compteur (138), ce qui force le VCO (oscillateur à tension de commande) (134) à émettre une nouvelle fréquence ou phase. Des circuits programmables de pré-division (114, 136) et de post-division (142) sont utilisés des deux côtés du compteur à rétroaction (138). Un microprocesseur ou d'une machine d'état logique charge des valeurs dans des registres (114, 140, 144) qui programment les diviseurs.
Patent EP-1311249-B1 (EP)
Inventor: WINDT-HANKE FRED
IPC: A61K47/34
Filed: 2001-08-24
Granted: 2009-10-07
Abstract: Use of a transdermal therapeutic system (TTS) comprising a pharmaceutical layer containing at least one matrix having an active ingredient and/or an active ingredient reservoir; a diffusion barrier that is permeable to said active ingredient and arranged on the skin side of the active ingredient reservoir; and an ergoline derivative or salt thereof as an active ingredient for producing an agent for obtaining and maintaining the circadian rhythm under dopamine therapy. The invention relates to the use of a transdermal therapeutic system (TTS) comprising a medicinal layer, which contains at least one matrix comprising an active ingredient and/or an active ingredient reservoir and a diffusion barrier situated on the skin side of the active ingredient reservoir and permeable to active ingredients, in addition to, an ergoline-derivative or physiologically compatible salt with an acid thereof, as an active ingredient, for producing a means for treating the restless-legs-syndrome. The invention relates to the use of a dopamine agonist in the form of an agent consisting of at least two spatially discrete compositions, of which one is a transdermal therapeutic system (TTS) containing the dopaminergic agent and another one or more are preparations for oral and/or parenteral application containing that same dopaminergic agent for the treatment of dopaminergically treatable diseases with the following elements: a) the TTS is continuously applied, b) within the duration of application in a) the composition for oral or parenteral dosage is administered. The invention concerns a transdermal therapeutic system containing ergoline derivatives, preferably lisuride, with a stabilized ergoline compound. Stabilization of the oxidation sensitive ergoline combination is done through a combination of at least one fat-soluble, radical-trapping antioxidant, preferably Di-tert.-butylmethylphenols, Di-tert.-butylmetoxyphenols, tocopherols or ubichinones and a basic polymer.
Patent EP-1339711-B1 (EP)
Inventor: PRESS NEIL JOHN
IPC: A61K31/497
Filed: 2001-11-19
Granted: 2005-07-27
Abstract: L'invention concerne des composés de formule (I) sous forme libre ou sous forme de sel, dans laquelle Ar désigne un groupe aromatique monovalent en C6-C15, R1 représente un hydrogène, un phényle éventuellement substitué par un ou plusieurs substituants sélectionnés dans un halogène, un cyano, un hydroxy, un C¿1?-C8-alkyle, un C1-C8-haloalkyle, un C1-C8-alcoxy, un C1-C8-alcoxy C1-C8-alkyle ou acyloxy, ou un groupe hétérocyclique monovalent à 5 ou 6 éléments, R?2¿ désigne un hydrogène, un C¿1-?C8-alkyle, un acyle ou un -CON(R?3)R4¿, pour autant que R2 désigne un C¿1?-C8-alkyle, un acyle ou un -CON(R?3)R4¿ quand R1 représente un hydrogène, R3 et R4 sont indépendamment un hydrogène ou un C¿1?-C8-alkyle, conjointement avec l'atome d'azote auquel ils sont rattachés représentant un groupe hétérocyclique à 5 ou 6 éléments, et Z?1, Z2, Z3 et Z4¿ désignent indépendamment N ou CR5, au moins un de ceux-ci représentant CR?5, et R5¿ désigne un hydrogène, un C¿1?-C8-alkyle ou un C1-C8-alcoxy. Les composés sont utiles comme antagonistes du récepteur de l'adénosine, notamment dans le traitement de maladies inflammatoires ou obstructives des voies aériennes.